Reduced acquisition and overgrowth of vancomycin-resistant enterococci and Candida species in patients treated with fidaxomicin versus vancomycin for Clostridium difficile infection.

Clin Infect Dis · 2012 · PMC3388028 · PMID 22752860

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

There was a nonsignificant trend toward more fidaxomicin-treated patients having negative culture results by the end of treatment (12 of 24 fidaxomicin-treated patients [50%] vs 6 of 25 vancomycin-treated patients [24%]; P = 0.07).

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.